EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020)
EARLY PHASE CLINICAL RESEARCH SUPPORT (Core 020)
批准号:
9316474
负责人:
ELIZABETH CLAIRE DEES
金额:
$28.19万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Acute Lymphocytic LeukemiaBiological MarkersCancer CenterCancer Center Support GrantChronic Lymphocytic LeukemiaClinical ResearchClinical SciencesClinical TrialsComplexComprehensive Cancer CenterConsultationsDevelopmentDrug KineticsEnrollmentEnvironmentFoundationsFundingGrantHodgkin DiseaseHuman ResourcesImageImmunotherapyIndustryLaboratoriesLeadershipMultiple MyelomaPaperPatientsPharmacodynamicsPhaseProtocols documentationRadiationRecruitment ActivityResearchResearch PersonnelResearch SupportResourcesReview CommitteeScienceSpecimenTalentsUNC Lineberger Comprehensive Cancer CenterUnited States National Institutes of HealthWorkbasedata managementexperiencefaculty supportinnovationinterestmembernovelnovel therapeuticspilot trialpre-clinicalprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract - Early Phase Clinical Research Support (EPCRS)
The Early Phase Clinical Research Support (EPCRS) provides critical resources for innovative short duration
research protocols at UNC Lineberger Comprehensive Cancer Center (LCCC) in the form of skilled and
specialized research coordinator, data management, and laboratory support. The trials supported by this
resource are: complex with strong correlative science and/or pharmacokinetic and pharmacodynamic
components; LCCC investigator-initiated; and primarily based on scientific expertise and interests of LCCC
members. Trials are selected from among those submitted to the Protocol Office Executive Committee for
review. Dr Claire Dees, EPCRS Faculty Director and co-leader, Clinical Research Program, in direct
consultation with Drs. Carey (Associate Director, Clinical Sciences) and Hayes (co-leader, Clinical Research
Program), makes the final selection. LCCC members conducted numerous innovative studies over the last five
years including those: evaluating novel compounds with radiation; involving novel combinations; and
incorporating novel correlative biomarkers and imaging. Many ECPRS supported trials originated in basic and
preclinical science in UNC Lineberger laboratories.
Since 2010, LCCC recruited a number of talented investigators actively growing our Phase I investigator
initiated trial portfolio and so we anticipate expanded ECPRS use. In addition, the inaugural trials of the UNC
immunotherapy center will begin in this cycle and will require additional specialized support. The first patients
will be enrolled on UNC immunotherapy trials in the spring of 2016 and these initial trials would include patients
with acute lymphoblastic leukemia, chronic lymphocytic leukemia, Hodgkin lymphoma, and multiple myeloma.
The strong commitment of the UNC Lineberger leadership to the development of novel therapeutics as a
Cancer Center strategic direction creates an environment that will generate even greater demand for
specialized support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
-
批准号:8725805
-
项目类别:
-
资助金额:$50.62万
-
财政年份:2014
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
-
批准号:8831627
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2014
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
CLINICAL TRIAL: LCCC 0509: A TWO-ARM PHASE I DOSE ESCALATION TRIAL OF VINFLUNINE
-
批准号:7716861
-
项目类别:
-
资助金额:$1.55万
-
财政年份:2008
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
MLN8054, AURORA A KINASE INHIBITOR IN PATIENTS WITH ADVANCED SOLID TUMOR
-
批准号:7625646
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2006
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
CALGB 60301: SORAFENIB FOR SOLID TUMORS AND HAM MALIGNANCIES
-
批准号:7625606
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2006
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
LCCC 0509: A TWO-ARM PHASE I DOSE ESCALATION TRIAL OF VINFLUNINE
-
批准号:7625662
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2006
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
COMBINATION OF PEGYLATED LIPOSOMAL DOXIL WITH PS-341 IN PATIENTS WITH MALIGNANC
-
批准号:7625512
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2006
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
Phase I Radiosensitization Study of GW572016 in Recurrent Breast Cancer
-
批准号:7156842
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2006
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
Phase I Radiosensitization Study of GW572016 in Recurrent Breast Cancer
-
批准号:7286834
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2006
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
CALGB 60301: SORAFENIB FOR SOLID TUMORS AND HAM MALIGNANCIES
-
批准号:7377558
-
项目类别:
-
资助金额:$1.76万
-
财政年份:2005
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
COMBINATION OF PEGYLATED LIPOSOMAL DOXIL WITH PS-341 IN PATIENTS WITH MALIGNANC
-
批准号:7200208
-
项目类别:
-
资助金额:$0.31万
-
财政年份:2004
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
NSABP P-1: Trial to Determine Worth of Tamoxifen for Preventing Breast Cancer.
-
批准号:6980567
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2003
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
Relationship Between Paclitaxel Pharmacokinetics and Phenotypic Markers
-
批准号:6980641
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2003
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
P450 PHENOTYPE AND CHEMOTHERAPY TOXICITY IN THE ELDERLY
-
批准号:6419129
-
项目类别:
-
资助金额:$12.41万
-
财政年份:2002
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
P450 PHENOTYPE AND CHEMOTHERAPY TOXICITY IN THE ELDERLY
-
批准号:6746019
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2002
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
P450 PHENOTYPE AND CHEMOTHERAPY TOXICITY IN THE ELDERLY
-
批准号:6892832
-
项目类别:
-
资助金额:$12.3万
-
财政年份:2002
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
P450 PHENOTYPE AND CHEMOTHERAPY TOXICITY IN THE ELDERLY
-
批准号:6620574
-
项目类别:
-
资助金额:$12.21万
-
财政年份:2002
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
P450 PHENOTYPE AND CHEMOTHERAPY TOXICITY IN THE ELDERLY
-
批准号:7062071
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2002
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
Clinical Protocol and Data Management (Core 018)
-
批准号:8999672
-
项目类别:
-
资助金额:$68.07万
-
财政年份:--
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
Clinical Protocol and Data Management (Core 018)
-
批准号:9316470
-
项目类别:
-
资助金额:$67.67万
-
财政年份:--
-
负责人:ELIZABETH CLAIRE DEES
-
依托单位:
海外基金